WILMINGTON, DE - After a week-long bench trial held in Delaware in May, Judge Richard Andrews ruled in Exelixis' favor this past Thursday, rejecting MSN's challenge to the cabozantinib compound patent (U.S. 7,579,473). Impact Trial's team members working with the...
WILMINGTON, DE - At the end of a five-day trial, a Delaware federal jury found that Evenflo Co. Inc's car seats infringed the two patents asserted by Wonderland Switzerland AG. Impact Trial worked with the Allen & Overy LLP team...
NEW YORK, NY – Impact celebrates this tremendous victory on behalf of our phenomenal clients at Paul, Weiss and ExxonMobil. Four years of hearings culminating in a landmark three-week trial where our clients faced charges of massive fraud and nearly...
New York, NY – After a 6-week trial in Brooklyn, it took a federal jury less than one day of deliberations to find NXIVM founder Keith Raniere guilty on all seven counts of sex trafficking and racketeering. We are incredibly...
WILMINGTON, DE – After a week-long trial and several hours of deliberation, a Delaware federal jury has found that Baxalta Inc. infringed on our client Bayer’s hemophilia treatment patent (U.S. Patent 9,364,520) which treats hemophilia and awarded our client $155...
LOS ANGELES, CA – After just over a day of deliberations, a California federal jury has found that Nikon Corp. did not infringe camera sensor patents jointly owned by lens maker Carl Zeiss and semiconductor maker ASML, allowing the Japanese...